Correction: Adjuvant olaparib in the subset of patients from Japan with BRCA1- or BRCA2-mutated high-risk early breast cancer from the phase 3 OlympiA trial
Crossref DOI link: https://doi.org/10.1007/s12282-023-01468-z
Published Online: 2023-05-12
Published Print: 2023-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Yamauchi, Hideko http://orcid.org/0000-0002-1450-7211
Toi, Masakazu
Takayama, Shin
Nakamura, Seigo
Takano, Toshimi
Cui, Karen
Campbell, Christine
De Vos, Liesbet
Geyer, Charles Jr
Tutt, Andrew
Text and Data Mining valid from 2023-05-12
Version of Record valid from 2023-05-12
Article History
First Online: 12 May 2023